Trials
Search / Trial NCT06430632

Early Robotic Gait Training After Stroke

Launched by BAYLOR RESEARCH INSTITUTE · May 21, 2024

Trial Information

Current as of February 08, 2025

Recruiting

Keywords

Exoskeleton Gait Training Inpatient Rehabilitation Physical Therapy Physical Rehabilitation And Medicine Randomized Controlled Trial Robotic Gait Training

ClinConnect Summary

The Early Robotic Gait Training After Stroke (ERA Stroke) trial is studying how effective robotic gait training (RGT) is compared to usual care (UC) for helping people recover their walking ability after a stroke. This trial is specifically for patients who are in the subacute phase of recovery, which means they are starting to regain function but may still need significant support. The research is taking place at the Baylor Scott & White Institute for Rehabilitation, and they are currently looking for participants.

To be eligible for this trial, individuals must be between 18 and 85 years old and have had any type of stroke. They should be medically stable and actively participating in rehabilitation at the facility. Participants need to have the ability to set goals for their walking recovery and must be able to manage bladder and bowel functions. Importantly, people with other serious neurological conditions, significant cognitive issues, or who are pregnant cannot participate. Those who join the trial can expect to engage in both robotic training sessions and standard rehabilitation practices, providing a unique opportunity to see how advanced technology might improve their recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18-85 years of age
  • All types of stroke
  • Acute/subacute phase of recovery
  • Medically stable as deemed by a physician
  • Undergoing medical care and rehabilitation at BSWIR
  • All genders, races, and ethnicities
  • Meets Ekso robotic exoskeleton frame limitations
  • Continence or on a program for bladder and bowel management
  • Capacity and goal for walking recovery
  • Exclusion Criteria:
  • Concurrent neurological diagnoses (e.g., TBI, degenerative, CNS neoplasm)
  • Profound cognitive impairment
  • Pregnancy

About Baylor Research Institute

Baylor Research Institute (BRI) is a leading clinical research organization affiliated with Baylor Scott & White Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on translational medicine, BRI conducts a wide range of clinical trials across various therapeutic areas, including cardiovascular, oncology, and neurology. The institute is committed to fostering collaborative partnerships with academic institutions, industry leaders, and healthcare professionals to enhance the development of novel therapies and interventions. Through rigorous scientific methodology and ethical standards, Baylor Research Institute strives to contribute significantly to the advancement of healthcare and to provide patients with access to cutting-edge treatments.

Locations

Dallas, Texas, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0